Danaher's Cepheid Wins FDA Clearance for Hemorrhagic Fever Test

• Danaher’s Cepheid received FDA clearance for its Xpert Hemorrhagic Fever Panel test.
• The multiplex PCR test detects several hemorrhagic fever viruses from a single sample in approximately 61 minutes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611031235PR_NEWS_USPR_____LA87961) on November 03, 2026, and is solely responsible for the information contained therein.